Lay summary: We developed a live attenuated HSV-1-vectored vaccine, expressing the EXP1, UIS3, and TMP21 malaria parasite liver-stage exported antigens as fusion proteins with the VP26 viral tegument protein. The gene discussed is XPO1; the disease is malaria.